Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions

被引:164
作者
Loy, CJ [1 ]
Sim, KS [1 ]
Yong, EL [1 ]
机构
[1] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 119074, Singapore
关键词
D O I
10.1073/pnas.0736237100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The androgen receptor (AR), a nuclear transcription factor, mediates male sexual differentiation, and its excessive action is associated with prostate cancer. We have characterized a negative regulatory domain in the AR hinge region, which interacted with filamin A (FLNa), an actin-binding cytoskeletal protein. FLNa interfered with AR interdomain interactions and competed with the coactivator transcriptional intermediary factor 2 to specifically down-regulate AR function. Although full-length FLNa was predominantly cytoplasmic, a C-terminal 100-kDa fragment of FLNa colocalized with AR to the nucleus. This naturally occurring FLNa fragment repressed AR transactivation and disrupted AR interdomain interactions and transcriptional intermediary factor 2-activated AR function in a manner reminiscent of full-length FLNa, raising the possibility that the inhibitory effects of cytoplasmic FLNa may be transduced through this fragment, which can localize to the nucleus and form part of the pre-initiation complex. This unanticipated role of FLNa adds to the growing evidence for the involvement of cytoskeletal proteins in transcription regulation.
引用
收藏
页码:4562 / 4567
页数:6
相关论文
共 37 条
[1]   The Rac1-and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin [J].
Bellanger, JM ;
Astier, C ;
Sardet, C ;
Ohta, Y ;
Stossel, TP ;
Debant, A .
NATURE CELL BIOLOGY, 2000, 2 (12) :888-892
[2]   Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2) [J].
Berrevoets, CA ;
Doesburg, P ;
Steketee, K ;
Trapman, J ;
Brinkmann, AO .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (08) :1172-1183
[3]   Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function [J].
Buchanan, G ;
Yang, MO ;
Harris, JM ;
Nahm, HS ;
Han, GZ ;
Moore, N ;
Bentel, JM ;
Matusik, RJ ;
Horsfall, DJ ;
Marshall, VR ;
Greenberg, NM ;
Tilley, WD .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (01) :46-56
[4]   Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling [J].
Calderwood, DA ;
Shattil, SJ ;
Ginsberg, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22607-22610
[5]   Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion [J].
Coppolino, MG ;
Woodside, MJ ;
Demaurex, N ;
Grinstein, S ;
StArnaud, R ;
Dedhar, S .
NATURE, 1997, 386 (6627) :843-847
[6]   INHIBITION OF NUCLEAR HORMONE-RECEPTOR ACTIVITY BY CALRETICULIN [J].
DEDHAR, S ;
RENNIE, PS ;
SHAGO, M ;
HAGESTEIJN, CYL ;
YANG, HL ;
FILMUS, J ;
HAWLEY, RG ;
BRUCHOVSKY, N ;
CHENG, H ;
MATUSIK, RJ ;
GIGUERE, V .
NATURE, 1994, 367 (6462) :480-483
[7]   Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities [J].
Ding, XF ;
Anderson, CM ;
Ma, H ;
Hong, H ;
Uht, RM ;
Kushner, PJ ;
Stallcup, MR .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (02) :302-313
[8]   The amino terminus of the human AR is target for corepressor action and antihormone agonism [J].
Dotzlaw, H ;
Moehren, U ;
Mink, S ;
Cato, ACB ;
Lluhí, JAI ;
Baniahmad, A .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (04) :661-673
[9]   Binding of hsp90-associated immunophilins to cytoplasmic dynein: Direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain [J].
Galigniana, MD ;
Harrell, JM ;
Murphy, PJM ;
Chinkers, M ;
Radanyi, C ;
Renoir, JM ;
Zhang, MJ ;
Pratt, WB .
BIOCHEMISTRY, 2002, 41 (46) :13602-13610
[10]   Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton [J].
Galigniana, MD ;
Housley, PR ;
DeFranco, DB ;
Pratt, WB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16222-16227